Buchang Pharmaceuticals announced that its controlling subsidiary Buchang Yingxi Trading has completed the industrial and commercial registration change for its capital increase and obtained a renewed business license, with registered capital increased from 1 million yuan to 5 million yuan. The company approved the capital increase proposal at the 52nd meeting of the fifth board of directors on July 21, 2026, making a cash capital increase at 1 yuan per share in proportion to its shareholding, and will continue to hold 90 percent equity in Buchang Yingxi Trading after completion. Buchang Yingxi Trading was established on February 14, 2025, with Zhang Chuang as its legal representative. Its business scope covers wholesale of daily necessities, wholesale of medical masks, sales of health food, sales of disinfectants, and sales of Class I and Class II medical devices.
Shandong Buchang Pharmaceuticals Co LtdControlling subsidiary completes capital increase, strengthening financial position.
Company itself completes capital increase and business registration change.
